|
House Bill 2050 |
House Author: Paddie et al. |
|
Effective: 9-1-19 |
Senate Sponsor: Kolkhorst |
House Bill 2050 amends the Health and Safety Code to revise consent requirements for the prescription of an antipsychotic or neuroleptic medication to a resident of a convalescent or nursing facility or related institution and to include certain conditions on the validity of consent by the resident to the prescription.